NorthWest Biotherapeutics Inc (NWBO)

[eagle8]

Thanks Peter.

Bio99
@BIO99_BIO99
Nineteen days after the $NWBO submission to the MHRA, the FDA without much fanfare announced an initiative that built on top of ORBIS called Cogent Global. It really went under the radar and I missed it and I haven't seen any $NWBO investor mentioning it. Why? Because it was (supposedly) for gene therapy. Nor did the FDA advertise it much. But read about it. It's for gene AND cell therapies. Its purpose is concurrent regulator review by everyone on novel gene [and cell therapies] for rare diseases [like GBM]. In other words, within days of the submission, all major regulators have had the setup to collaboratively examine the DCVax application for concurrent approval. Think about that. It's not even under the ORBIS name any more. Maybe I'm reading too much into it. But read it for yourself. https://natlawreview.com/article/fda-takes-first-step-toward-international-regulation-gene-therapies-treat-rare